CDK1 expression in breast cancer

被引：0
|
作者：
Lim, Yueh Ni [1 ]
Rhodes, Charles Anthony [3 ]
Teoh, Kean Hooi [3 ]
Ho, Gwo Fuang [2 ]
机构：
[1] Sarawak Gen Hosp, Dept Radiotherapy & Oncol, Sarawak, Malaysia
[2] Univ Malaya Med Ctr, Dept Clin Oncol, Kuala Lumpur, Malaysia
[3] Univ Malaya, Dept Pathol, Kuala Lumpur, Malaysia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.354
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P20-3
引用
收藏
页码：S1449 / S1449
页数：1
相关论文
共 50 条
  • [1] CDK1 in Breast Cancer: Implications for Theranostic Potential
    Izadi, Sepideh
    Nikkhoo, Afshin
    Hojjat-Farsangi, Mohammad
    Namdar, Afshin
    Azizi, Gholamreza
    Mohammadi, Hamed
    Yousefi, Mehdi
    Jadidi-Niaragh, Farhad
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (07) : 758 - 767
  • [2] NFIX suppresses breast cancer cell proliferation by delaying mitosis through downregulation of CDK1 expression
    Ma, Hai-Yan
    Sun, Rui
    Tian, Tian
    Zhou, Xue-Jie
    Chen, Zhao-Hui
    Cao, Xu-Chen
    Yu, Yue
    Wang, Xin
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [3] Cks1 regulates cdk1 expression: A novel role during mitotic entry in breast cancer cells
    Westbrook, Louise
    Manuvakhova, Marina
    Kern, Francis G.
    Estes, Norman R., II
    Ramanathan, Harish N.
    Thottassery, Jaideep V.
    CANCER RESEARCH, 2007, 67 (23) : 11393 - 11401
  • [4] Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
    Satoshi Nakayama
    Yasuhiro Torikoshi
    Takeshi Takahashi
    Tomokazu Yoshida
    Tamotsu Sudo
    Tomoko Matsushima
    Yuko Kawasaki
    Aya Katayama
    Keigo Gohda
    Gabriel N Hortobagyi
    Shinzaburo Noguchi
    Toshiyuki Sakai
    Hideki Ishihara
    Naoto T Ueno
    Breast Cancer Research, 11
  • [5] Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
    Nakayama, Satoshi
    Torikoshi, Yasuhiro
    Takahashi, Takeshi
    Yoshida, Tomokazu
    Sudo, Tamotsu
    Matsushima, Tomoko
    Kawasaki, Yuko
    Katayama, Aya
    Gohda, Keigo
    Hortobagyi, Gabriel N.
    Noguchi, Shinzaburo
    Sakai, Toshiyuki
    Ishihara, Hideki
    Ueno, Naoto T.
    BREAST CANCER RESEARCH, 2009, 11 (01):
  • [6] CDK2 and CDK1 specific activities: A novel prognostic indicator in early breast cancer
    Kim, S.
    Masuda, N.
    Inaji, H.
    Yoshidome, K.
    Tsujimoto, M.
    Akiyama, F.
    Ishihara, H.
    Hortobagyi, G. N.
    Ueno, N. T.
    Noguchi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Homology models for CDK1 and CDK1/cyclin B
    McGrath, CF
    Pattabiraman, N
    Gussio, R
    Zaharevitz, DW
    Sausville, EA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3780S - 3781S
  • [8] Targeting CDK1 in cancer: mechanisms and implications
    Qiushi Wang
    Ann M. Bode
    Tianshun Zhang
    npj Precision Oncology, 7
  • [9] Targeting CDK1 in cancer: mechanisms and implications
    Wang, Qiushi
    Bode, Ann M.
    Zhang, Tianshun
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [10] Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer
    Kim, S. J.
    Nakayama, S.
    Miyoshi, Y.
    Taguchi, T.
    Tamaki, Y.
    Matsushima, T.
    Torikoshi, Y.
    Tanaka, S.
    Yoshida, T.
    Ishihara, H.
    Noguchi, S.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 68 - 72
12345